Financial Data and Key Metrics Changes - The company reported full-year organic sales growth of 2%, operating EBITDA growth of 6%, and adjusted EPS of $1.68 per share, up 16% year-over-year [5][6][12] - Free cash flow generation was strong, with expectations for solid free cash flow conversion of greater than 90% in 2026 [12][21] Business Line Data and Key Metrics Changes - Healthcare and Water technologies saw fourth-quarter net sales of $821 million, up 4% year-over-year, driven by 3% organic growth [17] - Diversified Industrials reported fourth-quarter net sales of $872 million, a 3% decline year-over-year, with a 4% organic decline [18] - Organic sales for Healthcare and Water technologies grew 5% in the second half of 2025, while Diversified Industrials experienced a 1% decline [16] Market Data and Key Metrics Changes - Organic growth in Europe was up 2% year-over-year, while Asia-Pacific saw a 2% decline [16] - The company expects mid-single-digit growth in Healthcare and Water technologies for 2026, while Diversified Industrials is expected to grow in the low single digits [22] Company Strategy and Development Direction - The company aims to drive above-market organic growth and build a robust business system while maintaining a balanced capital allocation model [8][11] - The strategic priorities for 2026 include enhancing core values, focusing on growth, and continuing operational excellence [7][9] Management's Comments on Operating Environment and Future Outlook - Management noted a mixed macro environment, with expectations for mid-single-digit growth in Healthcare and Water technologies, while automotive demand is expected to be flat [12][13] - The company is seeing improving order trends in its Industrial Technologies business, indicating market stabilization [14] Other Important Information - The company completed the separation of Qnity Electronics and is focused on operational and portfolio transformation [6][7] - A $2 billion share repurchase authorization was announced, with $500 million executed in the fourth quarter of 2025 [11][50] Q&A Session Summary Question: Insights on industrial orders and channel inventories - Management indicated that industrial orders are picking up, particularly in aerospace, with low double-digit improvements expected [30][32] Question: Pricing and inflation outlook - The company does not expect significant headwinds from inflation and anticipates improvements in gross margins due to productivity initiatives [33] Question: Shelter business outlook - The Shelter business is expected to start slightly down in 2026 but improve throughout the year, aiming for flat performance overall [40] Question: Vitality Index and product innovations - The Vitality Index remains strong at about 30%, with new products contributing positively to both top-line growth and margins [42][44] Question: Margin improvements in diversified segments - Margin expansion in Diversified Industrials was attributed to favorable mix and productivity gains, with benefits from ongoing initiatives expected in the future [56] Question: M&A opportunities - The company is actively scouting M&A opportunities, particularly in the healthcare sector, to enhance its portfolio [106] Question: Water business growth in China - Slower growth in China is attributed to reduced industrial production, but the company expects to ramp up to mid-single-digit growth by the end of the year [68] Question: U.S. construction outlook - The outlook for U.S. construction is flat, with low single-digit growth expected in non-residential and repair and remodel sectors, offset by declines in residential [99]

Core Viewpoint - DuPont has revised its 2025 net sales forecast to approximately $6.87 billion, reflecting the planned spin-off of its electronics unit and the divestiture of its Aramids business [1][2] Group 1: Financial Forecasts - The company lowered its third-quarter adjusted profit forecast to $1.06 per share from an earlier forecast of $1.15 per share due to the sale of the Aramids business [2] - Previously, DuPont had forecasted 2025 net sales of $12.85 billion, indicating a significant reduction in expectations [2] Group 2: Business Divestitures - DuPont plans to sell its heat-resistant fiber business, Aramids, which includes brands like Kevlar, to Arclin for $1.8 billion as part of a broader reorganization [2] - The Aramids unit will be treated as discontinued operations starting in the third quarter [1] Group 3: Future Updates - The company will provide an update on its full-year adjusted profit forecast during its third-quarter earnings call as it finalizes its capital structure [3]